Mary Martin | Horizon Pharma

Mary Martin, Ph.D.

Senior Vice President, Global Regulatory, Quality and R&D Project Management

Dr. Martin joined Horizon Pharma in September 2014 as senior vice president, global regulatory, quality and R&D project management. Prior to joining Horizon Pharma, Dr. Martin served as the vice president of regulatory affairs, quality assurance and product development of Vidara Therapeutics. Prior to joining Vidara, from 2004 to 2012, Dr. Martin was the chief operating officer of AGI Therapeutics. From 1989-2003, Dr. Martin held positions at Elan Corporation, including managing director (biotechnology drug delivery business unit) and senior vice president, project & portfolio management (drug delivery).

Dr. Martin holds a PhD and BSc (honors) in pharmacology and a Certified Diploma in Accounting and Finance (Association of Certified Accountants).

      Powered by WordPress. Designed by Woo Themes